Physician profile
Fernando Grigera
NPI 1770579658
$4,150.68
in general payments reported to CMS, 2019-2025
17 companies · $961 in 2025
The $961 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $194 · 2020: $124 · 2021: $417 · 2022: $782 · 2023: $404 · 2024: $1,268 · 2025: $961.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,634.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,634.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $745.26 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Onyx Frontier |
| Boston Scientific Corporation | $710.73 | 2019-2025 | Rotapro, Synergy, Avvigo Guidance System |
| Abbott Laboratories | $513.56 | 2020-2025 | Mitraclip, Amplatzer Piccolo, Triclip |
| Abiomed | $506.54 | 2021-2025 | Impella |
| W. L. Gore & Associates, INC. | $486.63 | 2022 | |
| Asahi Intecc USA, INC. | $271.48 | 2022-2024 | Peripheral Vascular |
| Cvrx, INC. | $143.72 | 2025 | Barostim Neo System |
| Edwards Lifesciences Corporation | $133.99 | 2020-2024 | |
| Shockwave Medical, INC | $133.51 | 2025 | |
| Pfizer INC. | $130.80 | 2020-2024 | |
| E.R. Squibb & Sons, L.L.C. | $94.02 | 2023-2025 | Camzyos, Eliquis |
| Heartflow, INC. | $93.63 | 2025 | |
| Novartis Pharmaceuticals Corporation | $81.92 | 2021-2022 | |
| Medtronic Vascular, INC. | $42.44 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $30.95 | 2021-2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.93 | 2021 | |
| Amgen INC. | $14.57 | 2025 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fernando Grigera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.